Tu et al., 2017 - Google Patents
Biodegradable hybrid stomatocyte nanomotors for drug deliveryTu et al., 2017
View PDF- Document ID
- 495480026656728988
- Author
- Tu Y
- Peng F
- André A
- Men Y
- Srinivas M
- Wilson D
- Publication year
- Publication venue
- Acs Nano
External Links
Snippet
We report the self-assembly of a biodegradable platinum nanoparticle-loaded stomatocyte nanomotor containing both PEG-b-PCL and PEG-b-PS as a potential candidate for anticancer drug delivery. Well-defined stomatocyte structures could be formed even after …
- 239000003814 drug 0 title abstract description 87
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48792—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a colloid, emulsion, i.e. having at least a dispersed/continuous oil phase and a dispersed/continuous aqueous phase, dispersion or suspension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tu et al. | Biodegradable hybrid stomatocyte nanomotors for drug delivery | |
| Schattling et al. | Double-fueled Janus swimmers with magnetotactic behavior | |
| Mou et al. | Autonomous motion and temperature-controlled drug delivery of Mg/Pt-poly (N-isopropylacrylamide) Janus micromotors driven by simulated body fluid and blood plasma | |
| Wang et al. | Intelligent micro‐/nanorobots for cancer theragnostic | |
| Venugopalan et al. | Fantastic voyage of nanomotors into the cell | |
| Veselov et al. | Targeted delivery methods for anticancer drugs | |
| Sabir et al. | DNA based and stimuli-responsive smart nanocarrier for diagnosis and treatment of cancer: applications and challenges | |
| Rastegari et al. | An update on mesoporous silica nanoparticle applications in nanomedicine | |
| Hu et al. | Micro/nanorobot: A promising targeted drug delivery system | |
| Esteban-Fernández de Ávila et al. | Nanomotor-enabled pH-responsive intracellular delivery of caspase-3: toward rapid cell apoptosis | |
| Díez-Pascual | Surface engineering of nanomaterials with polymers, biomolecules, and small ligands for nanomedicine | |
| Esteban-Fernández de Ávila et al. | Acoustically propelled nanomotors for intracellular siRNA delivery | |
| Choi et al. | Light-guided nanomotor systems for autonomous photothermal cancer therapy | |
| Pijpers et al. | Hybrid biodegradable nanomotors through compartmentalized synthesis | |
| Ortiz-Rivera et al. | A supramolecular approach to nanoscale motion: polymersome-based self-propelled nanomotors | |
| Llacer‐Wintle et al. | Biodegradable small‐scale swimmers for biomedical applications | |
| Bozuyuk et al. | Light-triggered drug release from 3D-printed magnetic chitosan microswimmers | |
| Narayan et al. | Mesoporous silica nanoparticles: A comprehensive review on synthesis and recent advances | |
| Sonntag et al. | Nano-and micromotors designed for cancer therapy | |
| Wu et al. | Enzymatic/magnetic hybrid micromotors for synergistic anticancer therapy | |
| Wang et al. | Micro/nanomachines and living biosystems: from simple interactions to microcyborgs | |
| Wu et al. | Turning erythrocytes into functional micromotors | |
| Wang et al. | Nano/microscale motors: biomedical opportunities and challenges | |
| Gao et al. | Artificial micromotors in the mouse’s stomach: A step toward in vivo use of synthetic motors | |
| Jaradat et al. | Microfluidics technology for the design and formulation of nanomedicines |